"When the acquisition closed, Dr Lynch went from being the near-absolute leader of a mid-sized company to being one of many officers in one of the largest technology companies in the world. Dr Lynch struggled to work with his peers on an equal footing and to recognize that practices which might work fine in a company with less than US$1bn in sales simply would not work in a company with over US$127bn in annual revenue."
What does any of that have to do with the actual trial, which is, I think at least, about Lynch's activities before the buyout?
Biting the hand that feeds IT
